US 7,968,569 B2
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 7,968,569 B2
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Frederick Krass
Art Unit:
1612 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Agent:
Inventors:
Jerome B. Zeldis
Priority:
05/17/02
Filed:
05/15/03
Granted:
06/28/11
Expiration:
10/09/22
Abstract
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Cooperative Patent Classification (CPC)
A61A61K31/7048A61P31/12A61KY02A50/30Y02A

Analytics

Cases

Patent Assignments

Citations